Intellia Therapeutics's total assets for Q4 2025 were $842.13M, a decrease of -8.99% from the previous quarter. NTLA total liabilities were $170.73M for the fiscal quarter, a -3.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.